| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |